We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Health-related Quality of Life in General Slovenian Population

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01269489
Recruitment Status : Unknown
Verified March 2012 by Institute of Oncology Ljubljana.
Recruitment status was:  Recruiting
First Posted : January 4, 2011
Last Update Posted : March 26, 2012
Sponsor:
Information provided by:
Institute of Oncology Ljubljana

Brief Summary:
The purpose of the study is to obtain reference data on health-related quality of life for the functional and symptom scales and single items of the European Organisation for Research and Treatment of Cancer Core Quality-of-Life Questionnaire (EORTC QLQ C30) in a representative sample of Slovenian general population.

Condition or disease
Health-related Quality of Life

Detailed Description:
A sample of at least 600 people from the Slovenian population, randomly selected, age 18 years and more, representing geografic diversity, will take part in this postal survey. The EORTC QLQ C30 and a questionnaire about demografic data will be send by mail. This is the first study to obtain reference data from the EORTC QLQ C30 in a sample from the general Slovenian population. The results will serve as guidelines for interpreting health-related quality-of-life of different groups of patients.

Study Type : Observational
Estimated Enrollment : 600 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Health-related Quality of Life in General Slovenian Poplation Assessed by the European Organisation for Research and Treatment of Cancer (EORTC) Core Quality-of-Life Questionnaire QLQ-C30
Study Start Date : December 2010
Estimated Primary Completion Date : September 2012
Estimated Study Completion Date : September 2012

Group/Cohort
general population
a representative sample from general Slovenian population




Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 90 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
sample from general Slovenian population
Criteria

Inclusion Criteria:

  • age 18 y and more

Exclusion Criteria:

  • serious comorbidity
  • previously treated for cancer

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01269489


Contacts
Contact: Vaneja Velenik, PhD,MD +38615879661 vvelenik@onko-i.si
Contact: Vesna Zadnik, PhD,MD +38615879661 vzadnik@onko-i.si

Locations
Slovenia
Institute of Oncology Recruiting
Ljubljana, Slovenia, 1000
Contact: Vaneja Velenik, PhD,MD    +38615879661    vvelenik@onko-i.si   
Contact: Vesna Zadnik, PhD,MD    +3861 5879661    vzadnik@onko-i.si   
Principal Investigator: Vaneja Velenik, PhD, MD         
Sub-Investigator: Vesna Zadnik, PhD,MD         
Sub-Investigator: Danijela Strbac, MD         
Sponsors and Collaborators
Institute of Oncology Ljubljana
Investigators
Principal Investigator: Vaneja Velenik, PhD, MD Institute of Oncology Ljubljana Slovenia